TCM Biotech International (TPE:4169) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4169 TCM Biotech International Corp TPE:4169
52 GF Score
Price NT$157.00
GF Value NT$42.31
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is TCM Biotech International Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

TPE:4169 vs VRTX, REGN, RVMD: Short Interest Comparison

For the Biotechnology subindustry, TCM Biotech International's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TCM Biotech International Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TCM Biotech International's Short Interest distribution charts can be found below:

* The bar in red indicates where TCM Biotech International's Short Interest falls into.


TPE:4169
52GF Score
TCM Biotech International Corp TPE:4169
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is TCM Biotech International (TPE:4169) Overvalued in 2026?

Based on GuruFocus' analysis, TCM Biotech International stock appears to be overvalued. The current stock price of NT$157.00 is trading 271.1% above its estimated GF Value™ of NT$42.31. GuruFocus considers TCM Biotech International to be Significantly Overvalued.

Key valuation signals for TPE:4169:

  • Short Interest:
  • GF Value™: NT$42.31 vs. price of NT$157.00 (271.1% above fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the TPE:4169 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TCM Biotech International Business Description

Address No. 97, Section 1, Xintai 5th Road, 24th Floor-8, Xizhi District, Neihu District, Taipei, TWN, 221416
TCM Biotech International Corp is a Taiwan based biotechnology company. It is engaged in research and development of new biotech drugs, development of microbial strain cultivation and fermentation technology, biotechnology services, wholesale of medical equipment, and sales of functional foods. Its products includes medical equipment, medical testing platform, medical drugs, and others. The Group has two reportable segments: Segment A and Segment B. Segment A is the functional foods segment, while Segment B is the pharmaceuticals segment. It derives maximum revenue from pharmaceuticals segment. Geographically, the company operates in Taiwan and Other countries, of which it generates maximum revenue from Taiwan.
52GF Score

Get the complete analysis for TPE:4169

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$157.00
Price
NT$42.31
GF Value